DSIP: The Sleep-Inducing Peptide
Last updated: March 2026
Delta Sleep-Inducing Peptide is a naturally occurring nonapeptide first isolated from rabbit cerebral venous blood in 1977. It modulates sleep architecture, stress response, and has analgesic properties studied across multiple clinical trials.
Sequence Length
Isolated
IV Dose
📋 On this page
What Is DSIP?
DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) is an endogenous nonapeptide discovered by Schoenenberger and Monnier. Unlike most sleep aids, it doesn't cause sedation — it modulates the natural sleep cycle by promoting delta-wave (slow-wave) sleep stages.
Promotes delta-wave (slow-wave) sleep without sedative effects. Modulates the natural sleep-wake cycle rather than forcing unconsciousness like traditional hypnotics.
Reduces cortisol and corticotropin-releasing hormone (CRH) levels. Modulates LH and GH secretion patterns, acting as a broad neuroendocrine modulator.
Interacts with opioid receptor systems to produce analgesic effects. Clinical studies showed significant pain reduction in chronic pain patients over 5-10 day treatment courses.
Exhibits stress-protective properties by modulating the HPA axis. Research suggests DSIP can limit the adrenal cortex response to ACTH stimulation under stress conditions.
What the Research Shows
Context: DSIP has been studied in double-blind placebo-controlled trials since the 1980s. Results on sleep are promising but mixed — some trials show significant improvement while others are inconclusive. The analgesic data is more consistently positive.
Side Effects & Safety Profile
Study Citations
Self-Assessment
Who Researches DSIP?
This Research Is Commonly Explored By People Who...
- Are investigating peptide-based approaches to sleep optimization without traditional sedatives
- Want to understand endogenous sleep-regulating peptides and their mechanisms
- Are interested in the connection between sleep architecture, pain, and neuroendocrine function
- Are exploring alternatives for stress-related sleep disturbances
This Research May Not Be Relevant If...
- You expect immediate knockout-style sedation — DSIP modulates sleep architecture, not consciousness
- You want well-established long-term safety data — it doesn't exist for DSIP
- You need FDA-approved options — DSIP remains investigational
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
Key Takeaways
- Endogenous nonapeptide discovered in 1977
- Promotes delta-wave sleep without sedation
- Analgesic effects confirmed in clinical pilot
- Modulates cortisol and stress response
- Generally well-tolerated in short-term studies
- Not FDA approved — investigational only
- Sleep results are mixed across trials
- No long-term safety data available
- Exact receptor binding profile still debated
- Optimal dosing protocol not established
🔬 Verified Research Source
Third-party tested compounds from Swiss Chems — one of the most trusted research suppliers.
Affiliate link — supports HighPeptides at no extra cost. All Swiss Chems products include third-party lab testing certificates.
Research Supplies
Tools and supplies relevant to this research area.
As an Amazon Associate, HighPeptides earns from qualifying purchases.
DSIP is NOT FDA approved and is available only for research purposes. This page is for educational purposes only. Not medical advice. Research Only